Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10368838" target="_blank" >RIV/00216208:11110/17:10368838 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064165:_____/17:10368838

Výsledek na webu

<a href="https://academic.oup.com/eurheartj/article/38/35/2649/3893585" target="_blank" >https://academic.oup.com/eurheartj/article/38/35/2649/3893585</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1093/eurheartj/ehx321" target="_blank" >10.1093/eurheartj/ehx321</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease

Popis výsledku v původním jazyce

The cardiovascular system and in particular the myocardium are often critical targets in Systemic immune-mediated diseases (SIDs), even in asymptomatic patients, leading to a relevant negative burden on prognosis. However, there are at present no studies to recommend cardiac screening in all patients regardless of the clinical suspicion. Therefore, management of patients with SIDs should always include cardiological screening and follow-up in patients with clinically suspected cardiac involvement. It is hoped that this document will provide a first orientation to cardiologists and non-cardiology physicians in selecting an appropriate multidisciplinary diagnostic workup in SIDs-related myocardial disease, as well as personalised treatment. Furthermore, it is hoped that cardiologists will actively participate to conception and design of future immunosuppressive/immunomodulatory trials in well-characterized groups of SIDs patients with early/subclinical as well as established myocardial involvement. In fact, at present there is a relative paucity of evidence-based treat-to-target regimens in SIDs patients with myocardial involvement besides empirically driven intensification of conventional immunosuppression.

Název v anglickém jazyce

Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease

Popis výsledku anglicky

The cardiovascular system and in particular the myocardium are often critical targets in Systemic immune-mediated diseases (SIDs), even in asymptomatic patients, leading to a relevant negative burden on prognosis. However, there are at present no studies to recommend cardiac screening in all patients regardless of the clinical suspicion. Therefore, management of patients with SIDs should always include cardiological screening and follow-up in patients with clinically suspected cardiac involvement. It is hoped that this document will provide a first orientation to cardiologists and non-cardiology physicians in selecting an appropriate multidisciplinary diagnostic workup in SIDs-related myocardial disease, as well as personalised treatment. Furthermore, it is hoped that cardiologists will actively participate to conception and design of future immunosuppressive/immunomodulatory trials in well-characterized groups of SIDs patients with early/subclinical as well as established myocardial involvement. In fact, at present there is a relative paucity of evidence-based treat-to-target regimens in SIDs patients with myocardial involvement besides empirically driven intensification of conventional immunosuppression.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

European Heart Journal

ISSN

0195-668X

e-ISSN

—

Svazek periodika

38

Číslo periodika v rámci svazku

35

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

14

Strana od-do

2649-2662

Kód UT WoS článku

000410679500007

EID výsledku v databázi Scopus

2-s2.0-85029761067